Pharmaceutical Formulations - EP4233846
EP4233846
- Application Number
- EP23162978A
- Filing Date
- Jun 29, 2016
- Status
- Granted And Under Opposition
- Nov 1, 2024
- Grant Date
- Dec 4, 2024
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4233846B1 was granted to Gilead Sciences on Dec 4, 2024 following the initial filing on Jun 29, 2016 under the application number EP23162978A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary
Patent Family
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents